Skip to content

Safety, tolerability and effect of DLX-001 in healthy volunteers

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-503390-38-00
Enrollment
106
Registered
2023-04-12
Start date
2023-04-14
Completion date
2024-08-16
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unipolar depression (UD)

Interventions

None listed

Sponsors

Delix Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026